Mechanical and Electrical Dyssynchrony During His-Bundle Pacing Versus His-Bundle Area Right Ventricular Pacing

November 2, 2022 updated by: Medical University of Lodz

Mechanical and Electrical Dyssynchrony During His-Bundle Pacing (Selective and Non-selective) Versus His-Bundle Area Right Ventricular Pacing

The aim of this study is to evaluate mechanical and electrical cardiac dyssynchrony in patients with pacemakers and the right ventricular electrode implanted in His Bundle area.

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Detailed Description

Permanent His Bundle Pacing (HBP) is a well-known method of cardiac pacing which is increasingly used in everyday practice. After lead implantation in His Bundle area (HBA) capture of various tissues can be achieved: A. right ventricular myocardium near to HBP; B. cardiac conduction system selectively or nonselectively (with concomitant regional myocardium activation). The different excitability and refractory periods decide which tissue, myocardium or/and the conduction system is effectively paced. A lot of clinical trials revealed the advantage of HBP over apical ventricular pacing (AVP). HBP improves clinical (NYHA, quality of life, hospitalization rate) and echocardiographic (left ventricular dimension and ejection fraction) indicators of heart failure.

We are going to compare mechanical and electrical synchrony during the various type of myocardium activation: HBP (nsHBP or sHBP), RV pacing near HBA and native heart rhythm (if possible) in each patient recruited to the study. Adequate pacemaker programming will allow achieving different activations as shown above. The mechanical synchrony will be estimated by transthoracic echocardiography and the electrical one by the detailed analysis of ECG.

Study Type

Observational

Enrollment (Anticipated)

100

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Lodz, Poland, 93-216
        • Recruiting
        • Department of Electrocardiology Medical University of Lodz
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 100 years (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Patients with bradyarrhythmia and indications for de novo permanent pacemaker implantation. The decision for pacing lead placement in His Bundle is left for physician discretion. Patients after pacemaker system implantation with His Bundle successfully pacing are to be asked to participate in the study. After having written informed consent obtained patients are to be scheduled for ventricular synchrony evaluation with ECHO and ECG after 3-6 months after implant (mid-term) and after 12 months (long-term).

Description

Inclusion Criteria:

  • all adult patients after implantation of pacemaker system with pacing lead successfully captured His Bundle (selectively or/and nonselectively)

Exclusion Criteria:

  • not willing or incapable to give written informed consent;
  • previous implanted cardiac electronic device (pacemaker, implantable cardioverter-defibrillator, cardiac resynchronization therapy device)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Interventricular mechanical delay
Time Frame: Mid-term: 3-6 months after pacemaker implantation
InterVentricular Mechanical Dyssynchrony Parameter 1
Mid-term: 3-6 months after pacemaker implantation
Interventricular mechanical delay
Time Frame: Long term: 12-15 months after pacemaker implantation
InterVentricular Mechanical Dyssynchrony Parameter 1
Long term: 12-15 months after pacemaker implantation
Free-wall-LV-to-RV-delay
Time Frame: Mid-term: 3-6 months after pacemaker implantation
InterVentricular Mechanical Dyssynchrony Parameter 2
Mid-term: 3-6 months after pacemaker implantation
Free-wall-LV-to-RV-delay
Time Frame: Long term: 12-15 months after pacemaker implantation
InterVentricular Mechanical Dyssynchrony Parameter 2
Long term: 12-15 months after pacemaker implantation
Septal-to-posterior wall motion delay
Time Frame: Mid-term: 3-6 months after pacemaker implantation
IntraVentricular Mechanical Dyssynchrony Parameter 1
Mid-term: 3-6 months after pacemaker implantation
Septal-to-posterior wall motion delay
Time Frame: Long term: 12-15 months after pacemaker implantation
IntraVentricular Mechanical Dyssynchrony Parameter 1
Long term: 12-15 months after pacemaker implantation
Opposing wall motion delay
Time Frame: Long term: 12-15 months after pacemaker implantation
IntraVentricular Mechanical Dyssynchrony Parameter 2
Long term: 12-15 months after pacemaker implantation
Opposing wall motion delay
Time Frame: Mid-term: 3-6 months after pacemaker implantation
IntraVentricular Mechanical Dyssynchrony Parameter 2
Mid-term: 3-6 months after pacemaker implantation
systolic dyssynchrony index
Time Frame: Long term: 12-15 months after pacemaker implantation
Ventricular Mechanical Dyssynchrony Parameter 1
Long term: 12-15 months after pacemaker implantation
systolic dyssynchrony index
Time Frame: Mid-term: 3-6 months after pacemaker implantation
Ventricular Mechanical Dyssynchrony Parameter 1
Mid-term: 3-6 months after pacemaker implantation
QRS duration
Time Frame: Mid-term: 3-6 months after pacemaker implantation
Electrical dyssynchrony Parameter
Mid-term: 3-6 months after pacemaker implantation
QRS duration
Time Frame: Long term: 12-15 months after pacemaker implantation
Electrical dyssynchrony Parameter
Long term: 12-15 months after pacemaker implantation

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Radial strain
Time Frame: Mid-term: 3-6 months after pacemaker implantation
Additional Ventricular Mechanical Dyssynchrony Parameter 1
Mid-term: 3-6 months after pacemaker implantation
Radial strain
Time Frame: Long term: 12-15 months after pacemaker implantation
Additional Ventricular Mechanical Dyssynchrony Parameter 1
Long term: 12-15 months after pacemaker implantation
Left Ventricular Ejection Fraction
Time Frame: Mid-term: 3-6 months after pacemaker implantation
Global left ventricle function parameter
Mid-term: 3-6 months after pacemaker implantation
Left Ventricular Ejection Fraction
Time Frame: Long term: 12-15 months after pacemaker implantation
Global left ventricle function parameter
Long term: 12-15 months after pacemaker implantation
Global longitudinal strain
Time Frame: Mid-term: 3-6 months after pacemaker implantation
Global left ventricle function parameter 2
Mid-term: 3-6 months after pacemaker implantation
Global longitudinal strain
Time Frame: Long term: 12-15 months after pacemaker implantation
Global left ventricle function parameter 2
Long term: 12-15 months after pacemaker implantation
Left ventricular output track velocity-time integral
Time Frame: Mid-term: 3-6 months after pacemaker implantation
Global left ventricle function parameter 3
Mid-term: 3-6 months after pacemaker implantation
Left ventricular output track velocity-time integral
Time Frame: Long term: 12-15 months after pacemaker implantation
Global left ventricle function parameter 3
Long term: 12-15 months after pacemaker implantation
Diastolic Filling Time
Time Frame: Mid-term: 3-6 months after pacemaker implantation
Atrioventricular Dyssynchrony Parameter
Mid-term: 3-6 months after pacemaker implantation
Diastolic Filling Time
Time Frame: Long term: 12-15 months after pacemaker implantation
Atrioventricular Dyssynchrony Parameter
Long term: 12-15 months after pacemaker implantation

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

December 14, 2020

Primary Completion (ANTICIPATED)

October 30, 2022

Study Completion (ANTICIPATED)

December 31, 2022

Study Registration Dates

First Submitted

December 14, 2020

First Submitted That Met QC Criteria

January 5, 2021

First Posted (ACTUAL)

January 6, 2021

Study Record Updates

Last Update Posted (ACTUAL)

November 3, 2022

Last Update Submitted That Met QC Criteria

November 2, 2022

Last Verified

November 1, 2022

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Bradyarrhythmia

Clinical Trials on Device Programming

Subscribe